Skip to main content
. 2006 Jul 19;2006(3):CD003597. doi: 10.1002/14651858.CD003597.pub2

Naber 2000b.

Methods Randomised, double‐blind, double‐dummy, placebo‐controlled 
 Multicentre study: 84 North American centres
Participants Number: 688 women 
 Age: 16‐65 years 
 Inclusion criteria: symptomatic UAC
Interventions GROUP 1 
 3 days gemifloxacin (320 mg once daily)
GROUP 2 
 3 days ciprofloxacin (250 mg twice daily)
Outcomes Bacteriological response
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Low risk A ‐ Adequate